4
Changes in Ownership
Oruka Therapeutics, Inc. Filed Acc 0000907654-25-000023
Chief Medical Officer sold 7,000 shares at an average $30.61 ($214,293)
- Chief Medical Officer acquired 7,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Goncalves Joana · Chief Medical Officer
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-12-19 | Exercise or conversion : show line 1 in the form 10b5-1 | +3,500 | $6.84 | $23,940 | 5,018 | D |
| 2025-12-19 | Exercise or conversion : show line 2 in the form 10b5-1 | +3,500 | $7.80 | $27,300 | 8,518 | D |
| 2025-12-19 | Sale : show line 3 in the form 10b5-1 | −641 | $28.53 | $18,289 | 7,877 | D |
| 2025-12-19 | Sale : show line 4 in the form 10b5-1 | −1,787 | $29.62 | $52,935 | 6,090 | D |
| 2025-12-19 | Sale : show line 5 in the form 10b5-1 | −1,492 | $30.70 | $45,806 | 4,598 | D |
| 2025-12-19 | Sale : show line 6 in the form 10b5-1 | −3,080 | $31.58 | $97,263 | 1,518 | D |
| Open-market sales · 7,000 sh · avg $30.61 · $214,293 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-12-19 | Exercise or conversion : show line 7 in the form 10b5-1 Employee Stock Option (right to buy) | −3,500 | 225,063 | D |
| 2025-12-19 | Exercise or conversion : show line 8 in the form 10b5-1 Employee Warrant (right to buy) | −3,500 | 196,492 | D |
Loading xslF345X05/form4.xml…